4601 - 4610 of 8571 Results
Title
Year
- Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States2021OPENTitle: Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United StatesJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02074-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02074-2Citation Count: 18
- Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdown2021OPENTitle: Longitudinal observational study of boxing therapy in Parkinson’s disease, including adverse impacts of the COVID-19 lockdownJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02359-6Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-021-02359-6Citation Count: 11
-
OPENTitle: TP53INP1 exerts neuroprotection under ageing and Parkinson’s disease-related stress conditionJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-021-03742-4Best OA location URL: https://www.nature.com/articles/s41419-021-03742-4.pdfCitation Count: 17
- Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies2021OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 15
-
RESTRICTEDTitle: Disrupted rich-club organization of brain structural networks in Parkinson’s diseaseJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 226Issue #: 7Start Page: 2205End Page: 2217Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-021-02319-3Citation Count: 19
-
OPENTitle: Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 1Start Page: 117End Page: 125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00759-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9302534Citation Count: 12
-
OPENTitle: 32nd International Symposium on the Autonomic Nervous SystemJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 5Start Page: 591End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-021-00822-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10286-021-00822-5.pdfCitation Count: 2
- Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies2021OPENTitle: Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02323-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02323-1.pdfCitation Count: 17
-
OPENTitle: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 399End Page: 421Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02349-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02349-5.pdfCitation Count: 21
- Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology2021OPENTitle: Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathologyJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01240-4Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01240-4Citation Count: 49